We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Product Feasibility of a New Silicone Hydrogel Contact Lens

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01309100
First Posted: March 4, 2011
Last Update Posted: April 29, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Bausch & Lomb Incorporated
  Purpose
The objective of this study is to determine the clinical feasibility and to evaluate the product performance of investigational contact lens.

Condition Intervention
Myopia Device: Investigational Lens Device: Acuvue Oasys Lens Device: Air Optix Aqua Lens

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single (Participant)
Official Title: A Study to Evaluate the Product Feasibility of a New Silicone Hydrogel Contact Lens

Resource links provided by NLM:


Further study details as provided by Bausch & Lomb Incorporated:

Primary Outcome Measures:
  • Visual Acuity (Investigational vs Air Optix Aqua Lens) [ Time Frame: 1 week ]
    The mean difference in distance high contrast logMAR visual acuity(VA) between the investigational lens (RD2117-01) and the Air Optix Aqua control lens.

  • Visual Acuity (Investigational vs Acuvue Oasys Lens) [ Time Frame: 1 week ]
    The mean difference in distance high contrast logMAR visual acuity(VA) between the investigational lens(RD2117-01) and the Acuvue Oasys control lens.


Secondary Outcome Measures:
  • Comfort Throughout the Day (Investigational vs Acuvue Oasys Lens) [ Time Frame: 1 week ]
    The mean differences in comfort between the investigational lens (RD2117-01) and the Acuvue Oasys control lens. Comfort was measured on a scale of 0 to 100, with 100 being the most favorable score.

  • Comfort Throughout the Day (Investigational vs Air Optix Aqua Lens) [ Time Frame: 1 week ]
    The mean differences in comfort between the investigational lens(RD2117-01) and the Air Optix Aqua control lens. Comfort was measured on a scale of 0 to 100, with 100 being the most favorable score.


Enrollment: 144
Study Start Date: November 2010
Study Completion Date: January 2011
Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Investigational Lens
Bausch & Lomb investigational silicone hydrogel lens.
Device: Investigational Lens
Bausch & Lomb investigational silicone hydrogel lens on a daily wear basis for 1 week.
Active Comparator: Acuvue Oasys Lens
Johnson & Johnson Acuvue Oasys contact lens.
Device: Acuvue Oasys Lens
Johnson & Johnson Acuvue Oasys contact lens on a daily wear basis for 1 week.
Active Comparator: Air Optix Aqua Lens
Ciba Vision Air Optix Aqua contact lens.
Device: Air Optix Aqua Lens
Ciba Vision Air Optix Aqua contact lens on a daily wear basis for 1 week.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Subjects must have clear central corneas and be free of any anterior segment disorders.
  • Subjects must be adapted wearers of soft contact lenses, wear a lens in each eye, and each lens must be of the same manufacture and brand.
  • Subjects must be myopic and require lens correction

Exclusion Criteria:

  • Subjects with any systemic disease affecting ocular health.
  • Subjects using any systemic or topical medications that will, in the Investigator's opinion, affect ocular physiology or lens performance.
  • Subjects with an active ocular disease or are using any ocular medication.
  • Subjects with any "Present" finding during the slit lamp examination that, in the Investigator's judgment, interferes with contact lens wear.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01309100


Locations
United States, New York
Bausch & Lomb Incorporated
Rochester, New York, United States, 14609
Sponsors and Collaborators
Bausch & Lomb Incorporated
Investigators
Principal Investigator: Tara Vaz, OD Bausch & Lomb Incorporated
  More Information

Responsible Party: Bausch & Lomb Incorporated
ClinicalTrials.gov Identifier: NCT01309100     History of Changes
Other Study ID Numbers: 672E
First Submitted: March 3, 2011
First Posted: March 4, 2011
Results First Submitted: March 27, 2014
Results First Posted: April 29, 2014
Last Update Posted: April 29, 2014
Last Verified: March 2014